TYRP1 defines a proliferative melanoma cell subpopulation, driving malignant progression and therapy resistance via the GPNMB–Notch1–SOX10/MITF axis
Chengjun Hu, Lingmei Zhu, Pengju Fan, Xin Bu, Chenchen Zuo · 2026
Read TYRP1 defines a proliferative melanoma cell subpopulation, driving malignant progression and therapy resistance via the GPNMB–Notch1–SOX10/MITF axis by Chengjun Hu, Lingmei Zhu, Pengju Fan, Xin Bu, Chenchen Zuo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13527954.txt.
Description
Chengjun Hu and four colleagues identify in a 2026 study a fast-growing subgroup of melanoma cells marked by the protein TYRP1. Using single-cell gene data from patient tumors, plus lab-grown organoids, cell lines, and mouse grafts, the team traced how these cells drive growth and resist treatment.
TYRP1 switched on a second protein, GPNMB, which activated Notch1 signaling and raised two regulators, SOX10 and MITF, that in turn fed back to keep TYRP1 high. Blocking GPNMB or Notch1 broke the loop and slowed tumors. TYRP1-rich growths resisted immune checkpoint therapy yet responded better to the drug dabrafenib. The authors propose TYRP1 as a marker for sorting patients toward the treatment most likely to help.
Catalog record
| CREATOR | Chengjun Hu, Lingmei Zhu, Pengju Fan, Xin Bu, Chenchen Zuo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56386 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |